Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 106886578 | 10688657 | 8 | F | 20141213 | 20160628 | 20150102 | 20160705 | EXP | CN-009507513-1412CHN012937 | MERCK | 59.00 | YR | F | Y | 60.00000 | KG | 20160705 | MD | CN | CN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 106886578 | 10688657 | 1 | PS | EMEND | APREPITANT | 1 | Oral | 125 MG, ONCE, DAY 1 | 160 | MG | Y1248 | 21549 | 125 | MG | CAPSULE | 1X | |||
| 106886578 | 10688657 | 2 | SS | EMEND | APREPITANT | 1 | Oral | 80 MG, ONCE, DAY 2 | 160 | MG | Y1248 | 21549 | 80 | MG | CAPSULE | 1X | |||
| 106886578 | 10688657 | 3 | SS | EMEND | APREPITANT | 1 | Oral | 80 MG, ONCE, DAY 3 | 160 | MG | Y1248 | 21549 | 80 | MG | CAPSULE | 1X | |||
| 106886578 | 10688657 | 4 | C | MATRINE | 2 | Intravenous drip | 12 ML/CC, DAILY, STRENGTH : UNK | U | 0 | INJECTION | QD | ||||||||
| 106886578 | 10688657 | 5 | C | MATRINE | 2 | Intravenous (not otherwise specified) | 12 ML/CC, QD | U | 0 | INJECTION | QD | ||||||||
| 106886578 | 10688657 | 6 | C | SHEN QI FU ZHENG ZHU SHE YE | 2 | Intravenous drip | 250 ML/CC, DAILY, STRENGTH : UNK | U | 0 | INJECTION | QD | ||||||||
| 106886578 | 10688657 | 7 | C | SHEN QI FU ZHENG ZHU SHE YE | 2 | Intravenous drip | 250 ML/CC, DAILY, STRENGTH : UNK | U | 0 | INJECTION | QD | ||||||||
| 106886578 | 10688657 | 8 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | Intravenous drip | TOTAL DAILY DOSE 30 MG, TWO TIMES A DAY, STRENGTH : UNK | U | 0 | INJECTION | BID | |||||||
| 106886578 | 10688657 | 9 | C | TROPISETRON HYDROCHLORIDE | TROPISETRON HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | TOTAL DAILY DOSE 5 MG, BID (TWO TIMES A DAY), STRENGTH : UNK | U | 0 | INJECTION | BID | |||||||
| 106886578 | 10688657 | 10 | C | DEXAMETHASONE SODIUM PHOSPHATE. | DEXAMETHASONE SODIUM PHOSPHATE | 1 | Intravenous drip | 5 MG, DAILY, STRENGTH : UNK | 10 | MG | U | 0 | 5 | MG | INJECTION | QD | |||
| 106886578 | 10688657 | 11 | C | DEXAMETHASONE SODIUM PHOSPHATE. | DEXAMETHASONE SODIUM PHOSPHATE | 1 | Intravenous drip | 5 MG, DAILY, STRENGTH : UNK | 10 | MG | U | 0 | 5 | MG | INJECTION | QD | |||
| 106886578 | 10688657 | 12 | C | POTASSIUM CHLORIDE. | POTASSIUM CHLORIDE | 1 | Intravenous drip | 1 G, QD (DAILY), STRENGTH : UNK | 2 | G | U | 0 | 1 | G | INJECTION | QD | |||
| 106886578 | 10688657 | 13 | C | INSULIN | INSULIN NOS | 1 | Intravenous drip | 61 UNITS, QD (DAILY), STRENGTH : UNK | 122 | DF | U | 0 | 61 | DF | INJECTION | QD | |||
| 106886578 | 10688657 | 14 | C | CISPLATIN. | CISPLATIN | 1 | Intravenous drip | 40 MG, CYCLE: DAY1-DAY 3, TREATMENT CYCLE : 1/UNK, TREATMENT REGIMEN : GP | U | 0 | 40 | MG | INJECTION | ||||||
| 106886578 | 10688657 | 15 | C | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | Intravenous drip | 1.6 MG,CYCLE: DAY1AND DAY 8, TREATMENT CYCLE 1/UNK, TREATMENT REGIMEN : GP | U | 0 | 1.6 | MG | INJECTION | ||||||
| 106886578 | 10688657 | 16 | C | PAMIDRONATE DISODIUM. | PAMIDRONATE DISODIUM | 1 | Intravenous (not otherwise specified) | 90 MG, QD | 90 | MG | U | 0 | 90 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 106886578 | 10688657 | 1 | Prophylaxis of nausea and vomiting |
| 106886578 | 10688657 | 4 | Prophylaxis |
| 106886578 | 10688657 | 6 | Immunisation |
| 106886578 | 10688657 | 8 | Prophylaxis |
| 106886578 | 10688657 | 9 | Prophylaxis of nausea and vomiting |
| 106886578 | 10688657 | 10 | Prophylaxis of nausea and vomiting |
| 106886578 | 10688657 | 12 | Electrolyte imbalance |
| 106886578 | 10688657 | 13 | Hypoglycaemia |
| 106886578 | 10688657 | 14 | Chemotherapy |
| 106886578 | 10688657 | 15 | Chemotherapy |
| 106886578 | 10688657 | 16 | Adjuvant therapy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 106886578 | 10688657 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 106886578 | 10688657 | Dizziness | |
| 106886578 | 10688657 | Haematochezia | |
| 106886578 | 10688657 | Neutrophil count decreased | |
| 106886578 | 10688657 | Platelet count decreased | |
| 106886578 | 10688657 | White blood cell count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 106886578 | 10688657 | 1 | 20141209 | 20141209 | 0 | |
| 106886578 | 10688657 | 2 | 20141210 | 20141210 | 0 | |
| 106886578 | 10688657 | 3 | 20141211 | 20141211 | 0 | |
| 106886578 | 10688657 | 4 | 20141209 | 20141211 | 0 | |
| 106886578 | 10688657 | 5 | 20141205 | 20141208 | 0 | |
| 106886578 | 10688657 | 6 | 20141209 | 20141217 | 0 | |
| 106886578 | 10688657 | 7 | 20141207 | 20141208 | 0 | |
| 106886578 | 10688657 | 8 | 20141209 | 20141211 | 0 | |
| 106886578 | 10688657 | 9 | 20141209 | 20141212 | 0 | |
| 106886578 | 10688657 | 10 | 20141209 | 20141211 | 0 | |
| 106886578 | 10688657 | 11 | 20141205 | 20141205 | 0 | |
| 106886578 | 10688657 | 12 | 20141210 | 20141211 | 0 | |
| 106886578 | 10688657 | 13 | 20141210 | 20141211 | 0 | |
| 106886578 | 10688657 | 14 | 20141209 | 20141211 | 0 | |
| 106886578 | 10688657 | 15 | 20141209 | 20141216 | 0 | |
| 106886578 | 10688657 | 16 | 20141205 | 20141205 | 0 |